Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.54USD
−13.29 MUSD
1.99 BUSD
13.27 M
About REDCARE PHARMACY N.V.
Sector
Industry
CEO
Olaf Heinrich
Website
Headquarters
Sevenum
Employees (FY)
2.08 K
Founded
2001
ISIN
NL0012044747
FIGI
BBG00XTH5FR0
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. It operates under the DACH and International segments. The DACH segment includes medications and pharmacy-related BPC products sold to customers in Germany, Austria, and Switzerland. The International segment focuses on Belgium, the Netherlands, France, and Italy. The company was founded by Frank Köhler, Stephan Weber, and Marc Fischer in January 2001 and is headquartered in Sevenum, the Netherlands.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SHPPF is 148.00 USD — it has decreased by 1.50% in the past 24 hours. Watch Redcare Pharmacy NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Redcare Pharmacy NV stocks are traded under the ticker SHPPF.
We've gathered analysts' opinions on Redcare Pharmacy NV future price: according to them, SHPPF price has a max estimate of 204.23 USD and a min estimate of 117.17 USD. Watch SHPPF chart and read a more detailed Redcare Pharmacy NV stock forecast: see what analysts think of Redcare Pharmacy NV and suggest that you do with its stocks.
SHPPF reached its all-time high on Jan 20, 2021 with the price of 221.00 USD, and its all-time low was 43.15 USD and was reached on Oct 5, 2022. View more price dynamics on SHPPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SHPPF stock is 1.53% volatile and has beta coefficient of −0.01. Track Redcare Pharmacy NV stock price on the chart and check out the list of the most volatile stocks — is Redcare Pharmacy NV there?
Today Redcare Pharmacy NV has the market capitalization of 2.61 B, it has decreased by 8.08% over the last week.
Yes, you can track Redcare Pharmacy NV financials in yearly and quarterly reports right on TradingView.
Redcare Pharmacy NV is going to release the next earnings report on Jul 30, 2024. Keep track of upcoming events with our Earnings Calendar.
SHPPF net income for the last quarter is −8.42 M USD, while the quarter before that showed −6.16 M USD of net income which accounts for −36.71% change. Track more Redcare Pharmacy NV financial stats to get the full picture.
No, SHPPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 16, 2024, the company has 2.08 K employees. See our rating of the largest employees — is Redcare Pharmacy NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Redcare Pharmacy NV EBITDA is 101.85 M USD, and current EBITDA margin is 2.25%. See more stats in Redcare Pharmacy NV financial statements.
Like other stocks, SHPPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Redcare Pharmacy NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Redcare Pharmacy NV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Redcare Pharmacy NV stock shows the buy signal. See more of Redcare Pharmacy NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.